Cargando…
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
INTRODUCTION: Normal function of the p53 network is lost in most cancers, often through p53 mutation. The clinical impact of p53 mutations in breast cancer remains uncertain, especially where p53 isoforms may modify the effects of these p53 mutations. METHODS: Expression of p53β and p53γ isoforms, t...
Autores principales: | Bourdon, Jean-Christophe, Khoury, Marie P, Diot, Alexandra, Baker, Lee, Fernandes, Kenneth, Aoubala, Mustapha, Quinlan, Philip, Purdie, Colin A, Jordan, Lee B, Prats, Anne-Catherine, Lane, David P, Thompson, Alastair M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109573/ https://www.ncbi.nlm.nih.gov/pubmed/21251329 http://dx.doi.org/10.1186/bcr2811 |
Ejemplares similares
-
D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010) -
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
por: Moore, Hayley C, et al.
Publicado: (2010) -
D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008) -
p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010) -
TP53 drives invasion through expression of its Δ133p53β variant
por: Gadea, Gilles, et al.
Publicado: (2016)